Cargando…
JAK2 Exon 14 Deletion in Patients with Chronic Myeloproliferative Neoplasms
BACKGROUND: The JAK2 V617F mutation in exon 14 is the most common mutation in chronic myeloproliferative neoplasms (MPNs); deletion of the entire exon 14 is rarely detected. In our previous study of >10,000 samples from patients with suspected MPNs tested for JAK2 mutations by reverse transcripti...
Autores principales: | Ma, Wanlong, Kantarjian, Hagop, Zhang, Xi, Wang, Xiuqiang, Zhang, Zhong, Yeh, Chen-Hsiung, O'Brien, Susan, Giles, Francis, Bruey, Jean Marie, Albitar, Maher |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921382/ https://www.ncbi.nlm.nih.gov/pubmed/20730051 http://dx.doi.org/10.1371/journal.pone.0012165 |
Ejemplares similares
-
Structural effects of clinically observed mutations in JAK2 exons 13-15: comparison with V617F and exon 12 mutations
por: Lee, Tai-Sung, et al.
Publicado: (2009) -
Effects of Clinically Relevant MPL Mutations in the Transmembrane Domain Revealed at the Atomic Level through Computational Modeling
por: Lee, Tai-Sung, et al.
Publicado: (2011) -
Significant association between polymorphism of the erythropoietin gene promoter and myelodysplastic syndrome
por: Ma, Wanlong, et al.
Publicado: (2010) -
The role of the Exon 13 G571S JAK2 mutation in myeloproliferative neoplasms
por: Bahar, Burak, et al.
Publicado: (2016) -
JAK2 exon 12 mutation-positive myeloproliferative neoplasm associated with recurrent thromboembolism
por: Tavakoli, Vahid, et al.
Publicado: (2017)